March 7th, 2022

1 Sands Capital Research.
2 Sands Capital Research and initial patient data from Dexcom presentation at 2020 J.P. Morgan Healthcare conference in January 2020.
3 Sands Capital Research and J.P. Morgan 2022 Healthcare Conference held in January 2022.
4 Sands Capital Research and Edwards Lifesciences company data.
5 Sands Capital Research and data from J.P. Morgan Healthcare conference in January 2022.
6 Sands Capital Research.

Disclosures:

“Sands Capital” refers collectively to Sands Capital Management, LLC, which provides investment advisory services with respect to Sands Capital’s public market investment strategies, and Sands Capital Ventures, LLC, which provides investment advisory services with respect to Sands Capital’s private market investment strategies. As the context requires, the term “Sands Capital” may refer to such entities individually or collectively. The series of infographics features businesses and related companies that were selected to illustrate current underlying macroeconomic and sectoral trends. The series uses rotation whereby businesses featured are selected to highlight different trends across sectors and geographies. The Medical Devices infographic illustrates the businesses that provide wearable and portable healthcare devices that enable the personalization of treatment and further its reach. The companies shown are held in the following Sands Capital strategies: Select Growth (Dexcom, Edwards), Global Growth (Edwards, Dexcom, iRhythm), Life Sciences Pulse (Exo). This material is not intended as a forecast, a guarantee of future results, investment recommendations, or an offer to buy or sell any securities. The views expressed by Sands Capital and the information contained herein are current as of the date indicated and are subject to change. This material may contain forward-looking statements, which are subject to uncertainty and contingencies outside of Sands Capital’s control. Readers should not place undue reliance upon these forward-looking statements. There is no guarantee that Sands Capital will meet its stated goals. Past performance is not indicative of future results. References to companies provided for illustrative purposes only. The portfolio companies identified do not represent all of the securities purchased or recommended for advisory clients. There is no assurance that any securities discussed will remain in the portfolio or that securities sold have not been repurchased. You should not assume that any investment is or will be profitable. All company logos and website images are used for illustrative purposes only and were obtained directly from the company websites. Company logos and website images are trademarks or registered trademarks of their respective owners and use of a logo does not imply any connection between Sands Capital and the company.

You May Also Like

Investment Strategy
Digital Devices are Enabling a Healthier World
Healthcare companies are leveraging advances in technology to make smarter and smaller medical devices that enable earlier diagnosis and better treatment of disease.
Business Perspectives
The Tech that Powers a DoorDash Delivery
While ordering take out, a ride share, or some late-night snacks may seem like nothing more than the push of a button, it takes a web of innovative technology companies to make today’s ecommerce possible.
Impact
Dexcom’s Glucose Monitoring Device Makes Life with Diabetes Easier
Diabetes remains a chronic health issue, and the number of people who suffer from it continues to rise. The Dexcom G6 continuous glucose monitoring system enables them to wear a sensor that wirelessly transmits real-time glucose levels to their devices.
Perspectives Newsletter
Our latest thinking on innovation investing, long-term capital, and culture.

Something has gone wrong, check that all fields have been filled in correctly. If you have adblock, disable it.

The form was sent successfully